Given that TLE3/HDACs can inhibit Wnt/β-catenin signaling and that Wnt activation has adverse effects on the growth of melanoma cells, these results suggest that TLE3 might promote melanoma progression by regulating Wnt signaling (Ogawa et al., 2019). Here, TLE3 is linked to melanoma.